| Donepezil |
20070119 |
YASNAL, Film coated tablet, 10 mg, -, Pack: 28 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia; TAD Pharma GmbH, Германия |
11.89 |
2.38 |
14.27 |
6% |
0.71 |
12.6 |
2.52 |
15.12 |
18% |
2.14 |
14.74 |
2.95 |
17.69 |
НСР-8304/26.02.2016 |
02.04.2016 |
02.04.2016 |
|
|
Активен |
1724 |
| Donepezil |
№ II - 12796/01.04.2011 |
Yasnal Q-Tab, Orodispersible tablet, 5 mg, -, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения; TAD Pharma GmbH, Germany |
40.92 |
8.18 |
49.1 |
4% |
1.64 |
42.56 |
8.51 |
51.07 |
16% |
6.55 |
49.11 |
9.82 |
58.93 |
КЦ-2890/06.10.2011 г.; НСР-22067/31.07.2020 |
05.11.2011 |
02.09.2020 |
|
|
Заличен |
7288 |
| Donepezil |
№ II - 12796/ 01.04.2011 |
Yasnal Q-Tab, Orodispersible tablet, 5 mg, -, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения; TAD Pharma GmbH, Germany |
40.92 |
8.18 |
49.1 |
4% |
1.64 |
42.56 |
8.51 |
51.07 |
16% |
6.55 |
49.11 |
9.82 |
58.93 |
КЦ-2890/06.10.2011 г. |
05.11.2011 |
05.11.2011 |
|
|
Неактивен |
7288 |
| Donepezil |
№ II - 12797/01.04.2011 |
Yasnal Q-Tab, Orodispersible tablet, 10 mg, -, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения; TAD Pharma GmbH, Germany |
46.08 |
9.22 |
55.3 |
4% |
1.84 |
47.92 |
9.58 |
57.5 |
16% |
7.37 |
55.29 |
11.06 |
66.35 |
КЦ-2890/06.10.2011 г.; НСР-22067/31.07.2020 |
05.11.2011 |
02.09.2020 |
|
|
Заличен |
7287 |
| Donepezil |
№ II - 12797/ 01.04.2011 |
Yasnal Q-Tab, Orodispersible tablet, 10 mg, -, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения; TAD Pharma GmbH, Germany |
46.08 |
9.22 |
55.3 |
4% |
1.84 |
47.92 |
9.58 |
57.5 |
16% |
7.37 |
55.29 |
11.06 |
66.35 |
КЦ-2890/06.10.2011 г. |
05.11.2011 |
05.11.2011 |
|
|
Неактивен |
7287 |
| Ethinylestradiol, Drospirenone |
ІІ-4643/09.04.2009 |
Yaz, Film coated tablet, 0,02 mg/3,0 mg, -, Pack: 28 |
Bayer Schering Pharma AG,, Германия |
Bayer Schering Pharma AG, Germany; Schering GmbH & Co Producion KG, Germany |
14.67 |
2.93 |
17.6 |
6% |
0.88 |
15.55 |
3.11 |
18.66 |
18% |
2.64 |
18.19 |
3.64 |
21.83 |
КЦ-1044/
22,07,2009 г. |
10.08.2009 |
10.08.2009 |
|
|
Активен |
8056 |
| Bromfenac |
EU/1/11/692/001 |
Yellox, Eye drops, solution, 0.9 mg/ml - 5 ml, -, Pack: 1 |
Bausch Health Ireland Limited, Ирландия |
Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, Германия |
7.26 |
1.45 |
8.71 |
7% |
0.51 |
7.77 |
1.55 |
9.32 |
20% |
1.45 |
9.22 |
1.84 |
11.06 |
НСР-1482/21.10.2013 |
21.10.2013 |
02.08.2020 |
промяна на обстоятелства НСР-10895/10.11.2016; НСР-21889/09.07.2020 |
|
Активен |
8502 |
| Bromfenac |
EU/1/11/692/001 |
Yellox, Eye drops, solution, 0.9 mg/ml - 5 ml, -, Pack: 1 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, Германия |
7.26 |
1.45 |
8.71 |
7% |
0.51 |
7.77 |
1.55 |
9.32 |
20% |
1.45 |
9.22 |
1.84 |
11.06 |
НСР-1482/21.10.2013 |
21.10.2013 |
02.12.2016 |
промяна на обстоятелства НСР-10895/10.11.2016 |
|
Неактивен |
8502 |
| Bromfenac |
EU/1/11/692/001 |
Yellox, Eye drops, solution, 0.9 mg/ml - 5 ml, -, Pack: 1 |
Croma Pharma GmbH,, Австрия |
Croma Pharma GmbH, Austria; Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, Германия |
7.26 |
1.45 |
8.71 |
7% |
0.51 |
7.77 |
1.55 |
9.32 |
20% |
1.45 |
9.22 |
1.84 |
11.06 |
НСР-1482/21.10.2013 |
21.10.2013 |
21.10.2013 |
|
|
Неактивен |
8502 |
| Memantine |
20140327 |
Ymana, Film coated tablet, 5 mg, -, Pack: 7 |
Alkaloid – INT d.o.o., Словения |
Alkaloid-INT d.o.o., Словения |
4.89 |
0.98 |
5.87 |
7% |
0.34 |
5.23 |
1.05 |
6.28 |
20% |
0.98 |
6.21 |
1.24 |
7.45 |
НСР-8474/08.03.2016 |
23.03.2016 |
23.03.2016 |
|
|
Активен |
11699 |
| Dienogest |
20190164 |
Zafrilla, Tablet, 2, mg, Pack: 28 |
Gedeon Richter Plc., Унгария |
Gedeon Richter Plc., Унгария |
37.28 |
7.46 |
44.74 |
4% |
1.49 |
38.77 |
7.75 |
46.52 |
16% |
5.96 |
44.73 |
8.95 |
53.68 |
НСР-20309/05.12.2019 |
20.12.2019 |
02.01.2020 |
|
|
Активен |
16807 |
| Sertaconazole |
20080147 |
Zalain, pessary, 300 mg, -, Pack: 1 |
Ferrer International S.A.,, Испания |
Laboratoire Theramex, Монако; Trommsdorf GmbH & Co.KG, Германия |
4.67 |
0.93 |
5.6 |
7% |
0.33 |
5 |
1 |
6 |
20% |
0.93 |
5.93 |
1.19 |
7.12 |
НСР-1602/01.11.2013 |
02.12.2013 |
02.02.2020 |
Промяна на обстоятелства НСР-20441/19.12.2019 |
|
Активен |
8608 |
| Sertaconazole |
20080147 |
Zalain, pessary, 300 mg, -, Pack: 1 |
Унифарма ЕООД, България |
Laboratoire Theramex, Монако; Trommsdorf GmbH & Co.KG, Германия |
4.67 |
0.93 |
5.6 |
7% |
0.33 |
5 |
1 |
6 |
20% |
0.93 |
5.93 |
1.19 |
7.12 |
НСР-1602/01.11.2013 |
02.12.2013 |
02.12.2013 |
|
|
Неактивен |
8608 |
| Sertaconazole |
20080148 |
Zalain, cream, 2% - 20 g, -, Pack: 1 |
Ferrer International S.A.,, Испания |
Ferrer International S.A., Испания |
6.88 |
1.38 |
8.26 |
7% |
0.48 |
7.36 |
1.47 |
8.83 |
20% |
1.38 |
8.74 |
1.75 |
10.49 |
НСР-1602/01.11.2013 |
02.12.2013 |
02.02.2020 |
Промяна на обстоятелства НСР-20442/19.12.2019 |
|
Активен |
8607 |
| Sertaconazole |
20080148 |
Zalain, cream, 2% - 20 g, -, Pack: 1 |
Унифарма ЕООД, България |
Ferrer International S.A., Испания |
6.88 |
1.38 |
8.26 |
7% |
0.48 |
7.36 |
1.47 |
8.83 |
20% |
1.38 |
8.74 |
1.75 |
10.49 |
НСР-1602/01.11.2013 |
02.12.2013 |
02.12.2013 |
|
|
Неактивен |
8607 |
| Ranitidine |
II-0255 / 17.07.2007 г. |
ZANTAC, Solution for injection, 25mg/ml - 2 ml, -, Pack: 5 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmithKline S.p.A., Strada Provinciale Asolana 68, San Polo di Torrile, 43056 Parma, Italy |
4.46 |
0.89 |
5.35 |
7% |
0.31 |
4.77 |
0.95 |
5.72 |
20% |
0.89 |
5.66 |
1.13 |
6.79 |
НСР-1382/07.10.2013 |
31.10.2012 |
31.10.2012 |
КЦРР-1070/26.07.2012 г. |
|
Активен |
1307 |
| Ranitidine |
II-0254/17.07.2007 г. |
ZANTAC, effervescent tablet, 150 mg, -, Pack: 10 |
ГлаксоСмитКлайн ЕООД, България |
Glaxo Wellcome Production, France |
9.64 |
1.93 |
11.57 |
7% |
0.67 |
10.31 |
2.06 |
12.37 |
20% |
1.93 |
12.24 |
2.45 |
14.69 |
КЦ-114/
23,06,2008 г. |
22.07.2008 |
22.07.2008 |
пределната цена е заличена с Решение HCР-47140/24.09.2015 г. в сила от 11.10.2015. |
|
Заличен |
7687 |
| Ranitidine |
II-0253/17.07.2007 г. |
ZANTAC, Film coated tablet, 150 mg, -, Pack: 20 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmithKline Pharmaceuticals S.A.;Glaxo Wellcome S.A., Spain |
13.69 |
2.74 |
16.43 |
6% |
0.82 |
14.51 |
2.9 |
17.41 |
18% |
2.46 |
16.97 |
3.39 |
20.36 |
КЦ-114/
23,06,2008 г. |
22.07.2008 |
22.07.2008 |
|
|
Активен |
7688 |
| Filgrastim |
EU/1/08/495//007 |
Zarzio, solution for injection or infusion in pre-filled syringe, 48 MU/0,5 ml, -, Pack: 5 |
Sandoz GmbH, Австрия |
Sandoz GmbH, Austria |
368.17 |
73.63 |
441.8 |
4% |
10 |
378.17 |
75.63 |
453.8 |
16% |
25 |
403.17 |
80.63 |
483.8 |
НСР-6863/30.07.2015. |
02.09.2015 |
02.09.2015 |
|
|
Активен |
2599 |
| Idarubicin |
20030571 |
ZAVEDOS, Capsule, hard, 10 mg capsules, hard, -, Pack: 1 |
Pfizer Europe MA EEIG, Белгия |
Actavis Italy S.p.A., Италия |
75.71 |
15.14 |
90.85 |
4% |
3.03 |
78.74 |
15.75 |
94.49 |
16% |
12.11 |
90.85 |
18.17 |
109.02 |
НСР-7376/05.11.2015. |
02.12.2015 |
02.01.2019 |
Промяна на обстоятелства НСР-17474/13.12.2018 |
|
Активен |
2395 |
| Idarubicin |
20030571 |
ZAVEDOS, Capsule, hard, 10 mg capsules, hard, -, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Actavis Italy S.p.A., Италия |
75.71 |
15.14 |
90.85 |
4% |
3.03 |
78.74 |
15.75 |
94.49 |
16% |
12.11 |
90.85 |
18.17 |
109.02 |
НСР-7376/05.11.2015. |
02.12.2015 |
02.12.2015 |
|
|
Неактивен |
2395 |
| Idarubicin |
20030570 |
ZAVEDOS, Capsule, hard, 5, mg, Pack: 1 |
Pfizer Europe MA EEIG, Белгия |
Actavis Italy S.p.A., Италия |
39.64 |
7.93 |
47.57 |
4% |
1.59 |
41.23 |
8.25 |
49.48 |
16% |
6.34 |
47.57 |
9.51 |
57.08 |
НСР-7331/29.10.2015. |
02.12.2015 |
02.01.2019 |
Промяна на обстоятелства НСР-17536/13.12.2018 |
|
Активен |
1642 |
| Idarubicin |
20030570 |
ZAVEDOS, Capsule, hard, 5 mg capsules, hard, -, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Actavis Italy S.p.A., Италия |
39.64 |
7.93 |
47.57 |
4% |
1.59 |
41.23 |
8.25 |
49.48 |
16% |
6.34 |
47.57 |
9.51 |
57.08 |
НСР-7331/29.10.2015. |
02.12.2015 |
02.12.2015 |
|
|
Неактивен |
1642 |
| Ceftazidime and beta-lactamase inhibitor |
EU/1/16/109/001 |
Zavicefta, Powder for concentrate for solution for infusion, 2 g/0.5 g, -, Pack: 10 vials |
Pfizer Ireland Pharmaceuticals Operations Services Group, Ирландия |
GlaxoSmithKline Manufacturing S.p.A, Италия |
2104.86 |
420.97 |
2525.83 |
4% |
10 |
2114.86 |
422.97 |
2537.83 |
16% |
25 |
2139.86 |
427.97 |
2567.83 |
НСР-14965/01.02.2018; НСР-18668/20.05.2019 |
16.02.2018 |
02.07.2019 |
|
|
Заличен |
16022 |
| Ceftazidime and beta-lactamase inhibitor |
EU/1/16/109/001 |
Zavicefta, Powder for concentrate for solution for infusion, 2 g/0.5 g, -, Pack: 10 vials |
Pfizer Ireland Pharmaceuticals Operations Services Group, Ирландия |
GlaxoSmithKline Manufacturing S.p.A, Италия |
2104.86 |
420.97 |
2525.83 |
4% |
10 |
2114.86 |
422.97 |
2537.83 |
16% |
25 |
2139.86 |
427.97 |
2567.83 |
НСР-14965/01.02.2018 |
16.02.2018 |
02.03.2018 |
|
|
Неактивен |
16022 |